GenHenn Venture Fund

GenHenn Capital is a private single-family office and venture capital investor founded in 2022 and based in Cranbury, New Jersey. The firm focuses on private equity and venture investments, with stated emphasis on life sciences, healthcare, biotechnology, infrastructure, and information technology. In healthcare, it appears to back operating companies rather than develop therapeutics itself, with disclosed portfolio activity including companies such as Diligent Pharma, mend, Prana Thoracic, PreciseDx, Xenocor, and DermaSensor. The name "GenHenn Venture Fund" appears to refer to the firm's investment vehicle, including "GenHenn Venture Fund I," rather than to a standalone drug-development biotech company. As a result, it is best characterized as a healthcare-focused investment firm rather than an operating biotech or pharma company.